The Discounted Cash Flow (DCF) valuation of Genmab A/S (GMAB.CO) is 102.20 DKK. With the latest stock price at 1,419.50 DKK, the upside of Genmab A/S based on DCF is -92.8%.
Based on the latest price of 1,419.50 DKK and our DCF valuation, Genmab A/S (GMAB.CO) is a sell. selling GMAB.CO stocks now will result in a potential gain of 92.8%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 8.3% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 70.13 - 780.51 | 102.20 |
| Upside | -95.1% - -45.0% | -92.8% |